Episode notes
Rod Wong and Stephanie Sirota delve into the transformative potential of GLP-1 drugs, focusing on their impact on obesity and related diseases. Rod shares his insights into the next generation of obesity therapies and the opportunities they present for innovation and investment in the biotech sector.
PODCAST TEAM
Producer: Devon Leaver
Editor: Dominique Guerra
Featuring: Rod Wong, moderated by Stephanie Sirota, Chief Business Officer, and Partner at RTW Investments.
Stay tuned for part two of our discussion on GLP-1s where we welcome Dr. Rekha B. Kumar to the studio at RTW HQ.
FOLLOW US
Love our podcast? Follow us on LinkedIn at
Keywords
life scienceshealthcare investingbiotechGLP